Trialist Hub
The Trialist Hub comprises a clinical part and the translational hub, which complement each other.
Clinical Part
Coordinator
Johannes Levin
+49 89-4400-46465
Working group
Anna Kopczak, Lisa Ann Gerdes, Robert Perneczky
Translational Hub
The aim of the Translational Hub is to develop translational projects between basic science and clinical application to bridge this translational gap.
The Hub will assist with the development of translational projects by
- assessing the clinical need
- analyzing the feasibility
- designing clinical trials
- identifying academic and commercial partners
Translational projects that can be developed with the hub may encompass the development of diagnostic strategies or biomarkers as well as the identification of novel therapeutic strategies based on repurposed or novel drugs.
The hub will also act as a bridge and mediate the contact between basic researchers and supporting structures, such as academic/clinical research organizations (A/CRO), technology transfer organizations (TTO), intellectual property organizations (IPO) and others.
Contact
Paul Lingor
Neuro-Kopf-Zentrum MRI, Ismaninger Straße 22, 81675 Munich